IDEX Biometrics ASA: Mandatory notification of trade and disclosure of large shareholding

Summary by AI ^BETAClose X

IDEX Biometrics ASA has announced the redelivery of 6,607,910 shares to Anders Storbråten, the chair of the board, following the approval of its listing prospectus. These shares represent tranches from private placements completed in April and May 2026, with the redelivery increasing Storbråten's total holding to 12,335,515 ordinary shares. This increase means his stake now constitutes approximately 7.4% of the share capital and 15.96% of the votes, crossing the 10% and 15% thresholds under Norwegian securities law, based on a total of 77,308,932 outstanding shares.

Disclaimer*

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 29 April 2026, regarding the completion of a private placement of 9,696,969 shares at NOK 8.25 per share into two tranches (the "April 2026 Private Placement"). Reference is further made to the stock exchange announcement made by the Company on 29 May 2026 regarding the completion of a private placement of 2,500,000 shares at NOK 8.25 per share (the "May 2026 Private Placement").

Following the approval and publication of the listing prospectus, as announced in the stock exchange announcement on 15 June 2026, 6,607,910 shares, whereof 812,137 shares are pertaining to tranche 1 of the April 2026 Private Placement, 3,295,773 shares are pertaining to tranche 2 of the April 2026 Private Placement and 2,500,000 shares are pertaining to the May 2026 Private Placement, have been redelivered to Anders Storbråten, the chair of the board of directors of the Company (the "Share Lender") pursuant to the share lending agreements as described in the stock exchange announcements on 29 April 2026 and 29 May 2026.

Notification of the redelivery of shares in accordance with the Market Abuse Regulation article 19 is attached to this announcement.

Following the redelivery of borrowed shares, the Share Lender's holding of 5,727,605 ordinary shares in the Company (of which 3,850,973 ordinary shares is held directly, and 1,876,632 shares is held through Pinchcliffe AS), will be increased to 12,335,515 ordinary shares in the Company, constituting respectively approximately 7.4% and approximately 15.96% of the share capital and votes outstanding in the Company. Consequently, the Share Lender's total registered holding of shares will cross above the 10% and 15% thresholds pursuant to section 4-2 (1) of the Norwegian Securities Trading Act. The above calculations have been made based on a total of 77,308,932 outstanding shares in the Company currently registered in the Norwegian Register of Business Enterprises (the "NRBE").

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation Article 19 and section 4-2 and section 5-12 of the Norwegian Securities Trading Act.

About Us
IDEX Biometrics ASA (OSE: IDEX) develops and makes fingerprint biometric cards for access control, digital identity and payment. By authenticating identity through fingerprint biometrics rather than passwords, PINs or traditional credentials, IDEX enables secure and convenient access to physical and digital services. Fingerprint matching happens directly on the card, offline and without transmitting biometric data. Certified by Visa, Mastercard, FIDO2 and EAL6+, and backed by more than 250 patents and over USD 350 million invested in R&D, IDEX serves banks, enterprises and public sector organizations directly and through channel partners worldwide.

For more information, visit www.idexbiometrics.com